Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel (ETCat01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00527449
Recruitment Status : Completed
First Posted : September 10, 2007
Last Update Posted : January 15, 2010
Information provided by:
Klinikum Weissenfels

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2008
  Actual Study Completion Date : September 2008